GV (nerve agent)
|Molar mass||198.176 g/mol|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|(: / ?)|
GV (nerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime, and HI-6.
- Fusek J, Bajgar J (1994). "Treatment of intoxication with GV compound in laboratory rats". Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 37 (2): 57–62.
- Kassa J, Bajgar J (1996). "Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice". Acta Medica (Hradec Kralove) 39 (1): 27–30.
- Harvey SP, Cheng TC (2002). "Alteromonas undina"Identification, Purification, and Partial Characterization of the GV-Degrading Enzyme from ATCC # 29660 (pdf). Aberdeen Proving Ground: Edgewood.
- Bajgar J (1998). "Some Toxic Chemicals as Potential Chemical Warfare Agents - The Threat for the Future?". ASA Newsletter 1998 (6).